Contact

Our news

Latest news

December 18, 2025

Collaboration Leads to the Incoporation of Pepper Therapeutics: New Research into the Treatment of Pancreatic Cancer

Amsterdam UMC, Erasmus MC, Stichting Overleven met Alvleesklierkanker (Support Casper), Stichting RARE-NL, and Orfenix have jointly launched Pepper Therapeutics B.V. This new company has a clear societal mission: to develop the diabetes drug phenformin into a promising therapy for patients with pancreatic cancer.

Read more
Filter News Topics
December 18, 2025

Collaboration Leads to the Incoporation of Pepper Therapeutics: New Research into the Treatment of Pancreatic Cancer

Read more
October 13, 2025
In the mediaInvestmentNew venture

‘Invest International’ invests in Plantics to accelerate international scale up

Read more
October 7, 2025
In the mediaNew venture

InspectT receives convertible loan from Innovatiefonds Noord-Holland

Read more
September 26, 2025
In the mediaNew venture

AviSia Therapeutics receives convertible loan from Innovatiefonds Noord-Holland

Read more
September 8, 2025
In the mediaNew venture

First babies in the Netherlands protected against RSV by Amsterdam UMC invention

Read more
September 3, 2025
In the mediaNew venture

Amplio Pharma receives EMA approval for Phase 1b trial in patients with rheumatoid arthritis

Read more
July 8, 2025
In the mediaInvestmentNew venture

XO Ventures and CbusineZ invest €1.35 million in TrianecT to accelerate stroke detection in ambulances

Read more
June 30, 2025
In the mediaInvestmentNew venture

ICOS Capital invests in Plantics B.V. to accelerate scale up

Read more
May 27, 2025
New venture

Quantum-centric workflows for predicting RNA secondary structure

Read more
May 26, 2025
In the mediaNew venture

100% bio-based award-winning thin plywood by Koskisen, with Plantics circular bio-binder

Read more
Contact